Skip to main content

Advertisement

Log in

Improved health-related quality of life outcomes associated with SHH subgroup medulloblastoma in SIOP-UKCCSG PNET3 trial survivors

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Bhat SR, Goodwin TL, Burwinkle TM et al (2005) Profile of daily life in children with brain tumors: an assessment of health-related quality of life. J Clin Oncol 23:5493–5500

    Article  PubMed  Google Scholar 

  2. Bull KS, Spoudeas HA, Yadegarfar G et al (2007) Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: a follow-up study in PNET 3 trial survivors—On behalf of the CCLG (formerly UKCCSG). J Clin Oncol 25:4239–4245

    Article  PubMed  Google Scholar 

  3. Ellison DW, Dalton J, Kocak M et al (2011) Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol 121:381–396

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Ellison DW, Kocak M, Dalton J et al (2011) Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J Clin Oncol 29:1400–1407

    Article  PubMed Central  PubMed  Google Scholar 

  5. Kennedy C, Bull K, Chevignard M et al (2014) Quality of survival and growth in children and young adults in the PNET4 European controlled trial of hyperfractionated versus conventional radiation therapy for standard-risk medulloblastoma. Int J Radiat Oncol Biol Phys 88:292–300

    Article  PubMed  Google Scholar 

  6. Konczak J, Schoch B, Dimitrova A et al (2005) Functional recovery of children and adolescents after cerebellar tumour resection. Brain 128:1428–1441

    Article  PubMed  Google Scholar 

  7. Palmer SL, Armstrong C, Onar-Thomas A et al (2013) Processing speed, attention, and working memory after treatment for medulloblastoma: an international, prospective, and longitudinal study. J Clin Oncol 31:3494–3500

    Article  PubMed  Google Scholar 

  8. Schwalbe EC, Williamson D, Lindsey JC et al (2013) DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathol 125:359–371

    Article  CAS  PubMed  Google Scholar 

  9. Taylor MD, Northcott PA, Korshunov A et al (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123:465–472

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Taylor RE, Bailey CC, Robinson K et al (2003) Results of a randomized study of pre-radiation chemotherapy versus radiotherapy alone for non-metastatic medulloblastoma: the International Society of Paediatric Oncology United Kingdom Children’s Cancer Study Group PNET-3 study. J Clin Oncol 21:1581–1591

    Article  CAS  PubMed  Google Scholar 

  11. Wefers AK, Warmuth-Metz M, Pöschl J et al (2014) Subgroup-specific localization of human medulloblastoma based on pre-operative MRI. Acta Neuropathol 127:931–933

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was conducted on behalf of the UK Children’s Cancer and Leukemia Group (CCLG), and was supported by Grants from The Brain Tumour Charity and Cancer Research UK. Medulloblastomas investigated in this study were provided as part of CCLG approved biological study BS-2007-04. This study was conducted with ethics committee approval from Newcastle/North Tyneside and Trent RECs (study reference numbers 07/Q0905/71; MREC/02/4/019). The task of identifying associations between biological subtype and quality of survival was made possible by funding from the European Union’s Seventh Framework Programme (FP7/2007-13) under the project ENCCA, grant agreement HEALTH-F2-2011-261474.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven C. Clifford.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 22 kb)

Supplementary material 2 (DOCX 22 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bull, K.S., Kennedy, C.R., Bailey, S. et al. Improved health-related quality of life outcomes associated with SHH subgroup medulloblastoma in SIOP-UKCCSG PNET3 trial survivors. Acta Neuropathol 128, 151–153 (2014). https://doi.org/10.1007/s00401-014-1300-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-014-1300-4

Keywords

Navigation